How Long of a Dynamic 3′-Deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) PET Acquisition Is Needed for Robust Kinetic Analysis in Breast Cancer?

Documenti analoghi

• Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT in Lung Cancer
  di: Kairemo, Kalevi, et al.
  Pubblicazione: (2020)
• Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
  di: Kairemo, Kalevi, et al.
  Pubblicazione: (2020)
• Kinetic Analysis of 3′-Deoxy-3′-(18)F-Fluorothymidine ((18)F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy
  di: Menda, Yusuf, et al.
  Pubblicazione: (2009)
• Reproducibility of 3′-Deoxy-3′-(18)F-Fluorothymidine MicroPET Studies in Tumor Xenografts in Mice
  di: Tseng, Jeffrey R., et al.
  Pubblicazione: (2005)
• Molecular imaging of metastatic atrial angiosarcoma with positron emission tomography (PET) tracer 3′-deoxy-3′[((18))F]-fluorothymidine, [((18))F]-FLT imaging and early response evaluation
  di: Kairemo, Kalevi, et al.
  Pubblicazione: (2019)